Ulixacaltamide Study Findings

In this presentation, Praxis Precision Medicines presents the results of their Phase 2 clinical trial for a potential essential tremor medication.

[@deadlionfish]

I was a patient during Phase 2 trial and went all the way through. My evaluation is that Ulixacaltamide (Prax 944) is not effective and should not go to phase 3 trial. I had very few side effects but the efficacy is poor. I am opting for focused ultrasound

[@mike700se]

Are you sure you didnt get a Placebo?

[@mikailstar4270]

lying

[@darrylolivier9013]

I get this much improvement from Primidone, so this new drug would not be a replacement for Primidone for me. What I want to know is the improvement level and side effects of the combination of Ulixacaltamide and Primidone.